The Weekly Roundup
'Tis the season for the ‘best of’ lists. As I vacillated this week on whether to make my own, and thumbed through page-after-page-after-page of stories on the opioid crisis, I couldn’t help but be reminded that I was beginning to compile one of those “worst of” lists. Infant drug dependence. Opioid abuse among the elderly. The staggering numbers that make prescription opioid overdose the largest driver in drug overdose deaths in the nation.
We’ve talked on these pages about the role that pharmacists can play in curbing abuse: prevention efforts, community coalitions, and drug take-back programs, to name but a few. As we enter a new year, I would encourage you to drop us a line and let us know what we’ve missed. What is working in your stores? Have you seen some successes? We’d love to spread the learning and share your stories. You can reach me at email@example.com.
Here are few other stories that might be of interest:
- Working on the golf game? Forbes explores the decline in approvals at the FDA.
- Beyond the EpiPen: Peanut allergy guidelines may represent another good opportunity for collaboration between pharmacies and providers.
- More pre-inaugural prognosticating. What Trump could mean for community pharmacy.
- Need some more inspiration to keep those resolutions? Do your patients? Check out this video on how exercise shapes the brain.
- Dig tech but had to work this week? Check out the latest and greatest from the Consumer Electronics Show.
- Promising news in melanoma from the Spartans.
- Anything to add? Career advice he wishes he’d had at age 25.
[Editor’s note:] Our inboxes are stuffed with newsletters and our coffee tables stacked with magazines and industry digests. I’m sure yours are, too. So we’ve decided to run a weekly sampling of interesting stories, issues coverage, and business ideas we come across each week. We hope you’ll share some of your favorites, too. Drop us a line at firstname.lastname@example.org.